To read the full story, subscribe or sign in.

Potential predictor of sunitinib response in renal cell carcinoma identified

Oct. 10, 2012

BioWorld Science Conferences Biomarkers

Today's news in brief

BioWorld

BioWorld briefs for May 5, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for May 5, 2026

Axsome’s Auvelity cleared for large Alzheimer’s agitation market

BioWorld

Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...

The epidermal growth factor receptor in the inactive (left) and active (right) form.

Cytospire raises £61M series A to target EGFR in solid tumors

BioWorld

Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...

Bio Korea 2026: US policy risks shift to execution framework

BioWorld

Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...